Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up
Authors:
- Fernanda S. BachegaFBFernanda S. Bachega
- Caio V. SuartzCSCaio V. Suartz
- Madson Q. AlmeidaMadson Q. Almeida
- Vania B. BrondaniVBVania B. Brondani
- Helaine L. S. CharcharHCHelaine L. S. Charchar
- Amanda M. F. LacombeAmanda M. F. Lacombe
- Sebastião N. Martins-FilhoSMSebastião N. Martins-Filho
- Iberê C. SoaresISIberê C. Soares
- Maria Claudia N. ZerbiniMZMaria Claudia N. Zerbini
- Francisco T. DénesFDFrancisco T. Dénes
- Berenice MendoncaBMBerenice Mendonca
- Roberto I. LopesRLRoberto I. Lopes
Open Access
- 9 November 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6641
Abstract
Pediatric adrenocortical tumors (PACTs) represent rare causes of malignancies. However, the south/southeast regions of Brazil are known to have a high incidence of PACTs because of the founder effect associated with a germline pathogenic variant of tumor suppressor gene TP53. We aimed to retrospectively analyze the types of variables among hormone production, radiological imaging, tumor staging, histological and genetic features that were associated with the occurrence of malignancy in 95 patients (71% females) with PACTs from a unique center. The worst prognosis was associated with those aged > 3 years (p < 0.05), high serum levels of 11-desoxicortisol (p < 0.001), tumor weight ≥ 200 g (p < 0.001), tumor size ≥ 5 cm (p < 0.05), Weiss score ≥ 5 (p < 0.05), Wieneke index ≥ 3 (p < 0.001) and Ki67 ≥ 15% (p < 0.05). Furthermore, patients with MacFarlane stage IV had an overall survival rate almost two times shorter than patients with other stages (p < 0.001). Additionally, the subtractions of BUB1B-PINK1 (p < 0.05) and IGF-IR overexpression (p = 0.0001) were associated with malignant behavior. These results helped identify patients who are likely to have an aggressive course; further multicenter prospective studies are required to confirm our results. In conclusion, PACTs with these patterns of prognostic factors could be treated using an adjuvant approach that may improve the overall survival in such patients.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (143722/2021-2)
This publication has 41 references indexed in Scilit:
- Assessing the fit of parametric cure modelsBiostatistics, 2012
- Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adultsMolecular and Cellular Endocrinology, 2012
- Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patientsEuropean Journal of Endocrinology, 2012
- A practical guide to understanding Kaplan‐Meier curvesOtolaryngology–Head and Neck Surgery, 2010
- Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and SurvivalJournal of Clinical Oncology, 2009
- Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, BrazilPediatric Blood & Cancer, 2005
- Tumores do córtex adrenal na infânciaArchives of Endocrinology and Metabolism, 2004
- Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor RegistryJournal of Clinical Oncology, 2004
- Adrenal Cortical Neoplasms in the Pediatric PopulationAmerican Journal of Surgical Pathology, 2003
- Clinical, Hormonal and Pathological Findings in a Comparative Study of Adrenocortical Neoplasms in Childhood and AdulthoodJournal of Urology, 1995